VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PCRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PCRXPacira BioSciences, Inc.
$25.09$987M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPCRXQuarterly Cash Flow

Pacira BioSciences, Inc. (PCRX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Pacira BioSciences, Inc. (PCRX) quarterly cash flow statement — complete operating, investing & financing history

PCRX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations25.68M43.69M60.83M12.01M35.46M33.13M53.92M53.24M49.1M47.58M44.44M43.5M19.13M42.04M42.65M29.81M30.78M23.21M60.29M30.13M
Operating CF Margin %14.48%22.19%33.89%6.63%20.99%17.69%31.99%29.9%29.38%26.25%27.11%25.67%11.93%24.45%25.47%17.59%19.48%14.58%47.2%22.22%
Operating CF Growth %-27.58%31.86%12.82%-77.44%-27.78%-30.37%21.34%22.38%156.7%13.2%4.18%45.94%-37.85%81.08%-29.25%-1.09%154.76%-50.25%51.55%292.87%
Net Income2.92M1.64M5.43M-4.85M4.81M16.04M-143.47M18.89M8.98M24.87M10.86M25.76M-19.54M-10.1M-693K19.88M6.83M-5.13M17.66M19.08M
Depreciation & Amortization21.33M21.34M21.19M27.32M21.17M21.24M20.25M18.86M18.43M18.48M18.43M19.05M19.6M30.41M20.2M20.86M20.03M13.07M5.73M4.9M
Stock-Based Compensation13.54M13.5M13.98M15.47M14.55M12.27M13.23M12.52M13.15M12.42M12.53M10.96M11.99M12.68M12.68M11.54M11.19M010.79M10.46M
Deferred Taxes1.73M-3.74M8.07M752K1.4M3.51M1.11M12.54M3.46M6.6M4.91M11.44M-7.34M-10.84M702K2.16M29K-2.08M5.34M5.87M
Other Non-Cash Items-11.95M-3.75M28.16M11.52M-7.7M4.41M160.7M-5.19M-3.03M854K5.91M-17.5M30.13M22.1M10.63M-19.43M841K18.76M5.39M3.33M
Working Capital Changes-1.89M14.71M-15.99M-38.2M1.22M-24.33M2.09M-4.38M8.11M-15.65M-8.2M-6.21M-15.72M-2.21M-867K-5.22M-8.14M-1.41M15.38M-13.5M
Change in Receivables-1.57M-8.8M-897K-9.61M8.56M-12.65M4.13M-3.14M3.92M-8.6M2.12M-5.88M5.19M-4.93M-2.37M998K4.21M-13.5M18.38M-15.77M
Change in Inventory2.49M4.82M-9.51M-14.4M-8.47M-13.42M-8.43M-6.66M7.57M-7.83M-4.39M847K3.09M735K3.79M3.07M-5.11M-1.91M-1.95M-658K
Change in Payables-936K-2.93M-12.01M6.88M2.46M-325K637K9.75M-6.98M-1.07M-7.7M7.05M2.63M1.59M-577K-847K6.11M-9.44M-2.98M3.51M
Cash from Investing19.44M19.33M43.61M62.16M-25.63M-368K-52.16M-15.21M-15.53M8.37M-4.34M7.33M66.18M11.19M-47.52M19.16M-208.02M66.92M-35.08M3.03M
Capital Expenditures-2.72M-218K-3.87M-2.7M-8.55M-2.12M-4.09M-1.59M-2.84M-1.8M-3.39M-3.4M-6.57M-5.49M-5.18M-11.73M-7.67M-9.17M-13.08M-10.55M
CapEx % of Revenue1.54%0.11%2.16%1.49%5.06%1.13%2.43%0.89%1.7%0.99%2.07%2.01%4.09%3.19%3.09%6.93%4.85%5.76%10.24%7.78%
Acquisitions-335K000-16.7M0000000-72.75M000-12.75M-420.04M-2.97M-13M
Investments--------------------
Other Investing04.93M000000000072.75M000-19.25M-4M2.97M14.22M
Cash from Financing-59.4M-51.65M-257.48M-57.51M-2.99M-1.96M-2.85M24.98M-2.82M-1.78M-27.79M440K-153.91M-58.51M-7.78M-153.66M-181.59M361.41M3.05M5.91M
Debt Issued (Net)-5M-4.98M-205.24M-3.75M-2.81M-2.81M-2.81M48.99M-2.81M-2.81M-27.81M-2.81M-147.32M-59.38M-9.38M-166.34M-192.61M359.2M00
Equity Issued (Net)-54.39M-46.53M-50.04M-48.47M000-23.64M0000333K00006.03M00
Dividends Paid00000000000000000000
Share Repurchases-50.05M-48.25M-50.04M-50.04M000-25M000000000000
Other Financing-5K-143K-2.2M-5.29M-181K857K-32K-378K-4K1.03M25K3.25M-6.91M864K1.6M12.68M11.02M-3.83M3.05M5.91M
Net Change in Cash-14.24M10.96M-152.9M16.87M6.84M30.81M-1.09M63M30.75M54.18M12.31M51.27M-68.59M-5.29M-12.64M-104.69M-358.83M451.54M28.26M39.08M
Free Cash Flow22.96M43.47M56.96M9.31M26.91M31.01M49.83M51.65M46.27M45.79M41.04M40.09M12.56M36.55M37.47M18.07M23.11M14.05M47.21M19.58M
FCF Margin %12.94%22.08%31.73%5.14%15.93%16.56%29.56%29.01%27.68%25.26%25.04%23.66%7.84%21.25%22.38%10.67%14.63%8.83%36.96%14.44%
FCF Growth %-14.7%40.17%14.32%-81.96%-41.83%-32.26%21.4%28.81%268.26%25.29%9.53%121.87%-45.64%160.13%-20.63%-7.72%2429.54%-56.45%47.45%179.83%
FCF per Share0.561.011.280.200.580.631.081.020.890.880.790.770.270.800.820.340.500.321.040.43
FCF Conversion (FCF/Net Income)3.63x26.69x11.20x-2.48x7.37x2.07x-0.38x2.82x5.47x1.91x4.09x1.69x-0.98x-4.16x-61.55x1.50x4.51x-4.53x3.41x1.58x
Interest Paid002.7M4.97M2.71M5.23M3.2M03.97M2.7M4.13M3.17M17.63M9.68M8.93M4.72M9.97M01.51M1.9M
Taxes Paid00711K7.95M286K1.45M4.91M002.29M1.28M594K201K3.18M112K4.09M9K0812K1.45M